Business Growth & Innovation

Hanmi Group Announces 2030 Mid-to-Long-Term Growth Roadmap through "Hanmi Vision Day"

In December 2025, Hanmi Pharmaceutical, as a core operating company of Hanmi Group, announced a 'Mid-to-Long-Term Vision' under the catchphrase 'Once again, with creation and innovation'.
Hanmi Pharmaceutical, through creation and innovation based on the Dual Momentum (Fundamental Growth + Innovative Growth) strategy, will strengthen sustainable growth and global competitiveness continuously enhance. Based on this, we aim to leap beyond domestic boundaries to become a global Top-tier company.